Antigen-specific CD8 + T cell differentiation in response to infection is associated with specific changes in the chromatin landscape resulting in acquisition of the lineage-specific effector functions required for pathogen clearance. Lysine (K)-specific demethylase 6B (KDM6b) is a histone demethylase that specifically recognizes and removes methyl groups from K27 tri/dimethylation on histone 3. This histone modification is associated with a repressive transcriptional state, or, in combination with the active H3K4me3 mark, a bivalent epigenetic state. Resolution of bivalency at fundamental transcription factor loci has been shown to be a key mechanism for the initiation of CD8 + T cell differentiation. 
Introduction
Cellular differentiation and fate commitment is mediated by the spatial and temporal control of cellspecific gene expression. While transcription factors mediate the lineage specific expression of genes, alterations to the chromatin structure must first occur to allow the transcriptional machinery to access the DNA. Initiation of gene transcription requires extensive remodelling of chromatin into a structure that promotes transcriptional activation. For example, this may include increased accessibility, addition of H3K4me3 and removal of H3K27me3.
When the cell receives external differentiation signals, the subsequent chromatin remodelling involves enzymes that mediate the addition or removal of histone post translation modifications to establish a transcriptionally permissive chromatin landscape at differentiation-associated genes. Lysine (K)-specific demethylase 6B (KDM6b) is a histone demethylase that specifically recognizes and removes methyl groups from H3K27 tri/dimethylation (1) (2) (3) (4) . Methylation of K27 at histone H3 is functionally associated with transcriptional repression and gene silencing and hence, its removal is required to permit transcription. The JMJD catalytic domain of Kdm6b catalyses the removal of methyl marks from H3K27 via a Fe2+-dependent dioxygenase mechanism (5, 6) .
Several key studies have demonstrated a role for KDM6b in cellular differentiation and fate commitment in embryonic stem cells (ESCs) via removal of H3K27me3 at key lineage specifying genes (7) (8) (9) . This role for KDM6b has been extended to more mature cell populations such as macrophages and lymphocytes (2) . The targeting of KDM6b to specific gene loci appears to be linked via interactions with [lineage-determining?] transcription factors such as RUNX2, and KDM6b plays a role in macrophage activation by interaction with the transcription factor IRF4 (10).
In CD4
+ T lymphocytes, the differentiation of naïve T H 0 cells to T H 1 cells correlates with a decrease in H3K27me3 deposition and consequently the resolution of bivalency at the Tbx21 locus (11) . Interestingly, a recent study showed that knock down of Kdm6b in vivo prevented Th1 differentiation (12) . However, this did not appear to be due to a lack of resolution of the Tbx21 locus or a dramatic reduction in Tbx21-encoded T-bet expression but rather through altered KDM6b interactions with upstream co-factors (12) .
Further, the Weinmann group demonstrated a physical interaction of T-bet with KDM6b at the Ifng locus in vitro in primary CD4 + T cells (13) . In all these data suggest an essential role for KDM6b in CD4 + T cell lineage fate commitment and functional differentiation.
When a naïve CD8 + T cell differentiates into an effector CD8 + T cell, dramatic epigenetic changes occur to allow for the expression of lineage specific effector function (14) (15) (16) (17) . As seen upon naïve CD4 + T cell activation, antigen-specific CD8 + T cell differentiation is associated with the rapid resolution of bivalency at fundamental transcription factor loci to a permissive epigenetic signature (16) . What remains to be determined is whether KDM6b dependent H3K27 demethylation is a key step for initiating CD8 + T cell differentiation.
Ideally, to be able to fully dissect the role that KDM6b plays during distinct stages of virus-specific CD8 + T cell differentiation, a mechanism by which KDM6b levels can be regulated at distinct stages is required. The tetracycline (Tet) inducible system involves use of two distinct genetic elements to regulate target gene expression (18, 19) . It requires the generation of two lines of transgenic mice where one contains a tet response element (TRE) promoter that controls specific mRNA or short hairpin RNA (shRNA) expression, and another expressing a tet-transactivator that can activate the TRE promoter. Crossing transgenic mice with tissue-specific expression of the tTA (tet-off) transactivator with mice harboring TREdriven shRNA allows regulatable knockdown of specific endogenous genes. (20) (21) (22) . This study describes the generation of transgenic mice that express an inducible KDMB6b shRNA. These mice were then crossed with a variety of tTA-transgenic lines enabling either constitutive or inducible shRNA knockdown.
We utilised these mouse lines to initially probe the role of the KDM6b enzyme in regulating CD8+ T cell differentiation in response to infection, with these mice providing a novel resource to study KDM6b knockdown in a variety of other cellular contexts.
Materials and Methods

Mice, viruses and infection.
Mice (6-10 weeks old) were bred and housed under specific pathogen free conditions in either; the 
Generation of shRNA retroviruses
Retroviral stocks encoding shRNAs designed to target Kdm6b (Table 1) were generated via transfection of Generation of shRNA transgenic mice.
Effective shRNA sequences identified using the LMP-EBFP2 vector were excised with XhoI/EcoRI and cloned into a variant of the pCol-TGM vector (24) , linking the shRNA to expression of green fluorescent protein (GFP) under control of the TRE3G promoter. This construct was targeted to the Col1a1 locus in mouse ES cells as described in (24) , and these cells were used to generate KDM6b shRNA transgenic mice.
Mice were then crossed onto the CMV-rtTA or Vav-tTA transgenic mouse strains (25) 
RNA extraction, reverse transcription and RT-PCR
Purified cell were lysed in 0.5-1 ml TRIzol reagent (Invitrogen) for 5 min at RT. RNA was extracted using DNase buffer and 10 U of RNase OUT (Invitrogen) for 20 mins at RT. RNA was then purified and concentrated using QIAgen RNeasy MinElute kit (Qiagen, Hilden, Germany). For reverse transcription, RNA was quantified using a NanoDrop 3300 spectrophotometer (ThermoFisher Scientific) and cDNA synthesized using the Omniscript RT kit (Qiagen) with 2 µM Oligo(dT) 15 Protein-chromatin complexes were purifed with Protein A Agarose/Salmon Sperm DNA beads for 1 hr at 4ºC followed by two sequential washes each of; low salt buffer, high salt buffer, LiCl buffer and TE buffer. Samples were probed by quantitative PCR using primers designed to target specific gene loci (Table 2) . 
Results
Development of an inducible and reversible Kdm6b knockdown mouse
The tetracycline (tet)-responsive system can be used to reversibly knock down endogenous gene expression by RNA interference (RNAi) (20, 21, 24, 25) . To generate shRNA transgenic mice, we first tested a panel of hairpins against KDM6b (Table 1) 
Figure. 1
Validating shRNA panels against KDM6b in vitro. 3T3 cells were transduced with lentiviral-shRNA at MOI~1 and selected using puromycin. Flow cytometry plots demonstrate efficiency of selection as determined by eBFP expression (a). Four days following selection, cells were ficoll purified, RNA was extracted with TRIzol reagent, cDNA generated and subjected to qPCR for L32, and Kdm6b with Taqman primer probes. PCR results were normalised to L32 and the relative gene expression of Kdm6b was determined and shown relative to the non-silencing control (b). To determine protein knockdown, lysates were collected following purification as above and probed with indicated antibodies (c). Murine cell lines were probed for L32 and Kdm6b as described in b. at the resting state or following 4 h stimulation with indicated mitogen (d). EL4 cells were transduced with lentiviral-shRNA as described in a. and Kdm6b mRNA knockdown was determined as described in b. (e). Data shown are mean+sem and are representative of 3-6 independent experiments or preliminary (d), *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. MEF lines isolated from the Luc shRNA .CAG-rtTA cross were GFP + (Fig 2b) . To confirm that Kdm6b knockdown was a reflection of RNA levels, qRT-PCR was performed on GFP + MEFs described above. Importantly, Kdm6b mRNA levels were equivalent in untreated Luc hRNA and Kdm6b shRNA MEFs (Fig. 2c) . Upon doxycycline treatment, Kdm6b expression was significantly reduced in Kdm6b
Generation of Tetracyline transactivator transgenic mice for
shRNA MEFs compared to Luc shRNA control MEFs (Fig. 2c) .
Having validated Dox- (Fig. 2d ). We observed a high level of Kdm6b knockdown within DP thymocytes with also substantial knockdown observed in naive CD4 + T cells (Fig. 2d) (Fig. 3a, b) . This indicates that Kdm6b knockdown impacts thymocyte development. Overall cell numbers were not overtly impacted due to an increase in the frequency of GFP med cells in Kdm6b shRNA mice, compared to Luc shRNA mice in these subsets (Fig. 3a, b) . Kdm6b and Luciferase hairpin controls (Fig. 3a, b , lower panels) with selective outgrowth of GFP lo Mϕs bearing the Kdm6b hairpin, compared to the Luciferase control. Taken together, these data suggest that constitutive expression of the Kdm6b shRNA impacts cellular development of hematopoetic cells. This is particularly apparent in thymic subsets and CD4 + splenocytes.
Kdm6b knockdown impairs T cell development in the thymus.
To further explore the impact of shRNA on T cell development, we assessed the proportion of DN, DP, (Fig. 4b) . The frequency of DN1, DN3 and DN4 subsets were comparable between Kdm6b shRNA and Luc shRNA control mice (Fig. 4b) . Therefore, it is possible that KDM6b plays a role in the transition from the DN1 to DN2 phase of T cell development in the thymus.
To determine if KDM6b may also be impacting on T cell positive selection, we compared expression of CD69 and CD5 on GFP hi thymocytes between Kdm6b shRNA and Luc shRNA control mice (Fig. 4c) . There was a small but significant decrease in the frequency of CD69 + CD5 + cells expressing the Kdm6b shRNA compared to the Luciferase control (Fig. 4c) (Fig. 4e) .
This suggests that Kdm6b knockdown may increase sensitivity to negative selection. Taken together, this further supports the notion that KDM6b may play a role in fine tuning sensitivity of thymocytes. (Fig. 5a, b) . This appeared to be compensated for by an increase in the frequency of GFP lo CD4 + T cells in Kdm6b shRNA transgenic mice (Fig. 5a, b (Fig. 5b) . Hence, it is possible that KDM6b knockdown actually supports mature CD8+ T cell differentiation.
KDM6b is involved in the maintenance of CD4 + T cells in the periphery
Given that KDM6b knockdown within the GFP hi expressing subsets resulted in a lower proportion of splenic CD4 + T cells, the phenotype of GFP hi CD4 + T cells was analysed (Fig. 5c) . Despite a lower proportion of total GFP hi CD4+ T cells within Kdm6b shRNA mice, there was an increase in the proportion of these cells exhibiting an activated phenotype (CD44 + CD62L lo ) when compared to those expressing a high level of the Luciferase control hairpin (Fig. 5c) . Taken together, these data indicate that KDM6b dysregulation in steady state appears to impact mature, naive CD4 + T cell development and persistence.
KDM6b knockdown did not impact the proportion of splenic NK cells (NK1.1+), dendritic cells (CD11c+) or macrophages/monocytes (F4/80+) compared to the Luciferase control hairpin (Fig. 5d) . Interestingly, there was an increased proportion of GFP hi B220+ B cells in the spleens of Kdm6b shRNA compared to Luc shRNA transgenic mice (Fig. 5d) .
KDM6b knockdown results in dysregulation of an influenza-specific T cell response.
While no impact on the proportion of naïve CD8 + T cells was observed, the initial hypothesis was that KDM6b would play a role in CD8 + T cell differentiation, via the resolution of key transcription factor loci that mediate the lineage specific function of these cells (16 A/HKx31 and weight loss measured over ten days (Fig. 6a) . Both groups of mice lost a comparable amount of weight following infection and recovered fully, indicating no gross defects in viral clearance and pathology. As is seen in the naïve state, high expression of the Kdm6b shRNA in the spleens resulted in a dramatic decrease in the frequency of CD4 + T cells at the peak of the immune response (Fig. 6b, c) , with no significant difference in the proportion CD8 + T cells between the Luc shRNA and
Kdm6b
shRNA transgenic mice (Fig. 6b) . The preliminary trend seen for an increase in B220 + B cells in the presence of the Kdm6b hairpin in the naïve state remained consistent following infection (Fig. 6b, c) . This is interesting given recent data showing a role for H3K27me3 in regulating germinal B cell responses (31 (Fig. 7a-c) .
Surprisingly, this trend was the opposite for I-A b /HA 211 -specific CD4 + T cells which displayed an increase in frequency compared to the Luc shRNA controls but no difference in total cell number (Fig. 7a-c) . There was no difference in the frequency of either IAVspecific CD8 + and CD4 + T cell responses, within the GFP -populations from Luc shRNA and Kdm6b shRNA transgenic mice (Fig. 7) indicating the impact was due to Kdm6b shRNA expression. Hence, these data suggest that KDM6b may in fact play distinct roles in either IAV-specific CD8 + vs CD4 + T cell responses.
KDM6b may play a role in resolving bivalency of key transcription factor loci
Further, we have previously shown that in the naive state, the Tbx21 locus in CD8 + T cells is marked with the permissive H3K4me3 and repressive H3K27me3 histone PTMs. Upon naive CD8+ T cell activation, the Tbx21 locus is rapidly resolved to a permissive state following activation via loss of the KDM6b substrate H3K27me3 (16) . To assess whether KDM6b expression played a role in regulating this resolution, we analysed the epigenetic signature of key transcription factors important for CD8 + T cell differentiation in the presence of the KDM6b hairpin at the peak of the immune response to IAV.
Naïve Luc shRNA and Kdm6b shRNA transgenic mice were infected with A/HKx31 and ten days post infection, cells were harvested from the spleens of Luc shRNA and Kdm6b shRNA mice and analysed for T-bet protein expression directly ex vivo by ICS on activated (CD44 hi ) CD4 + and CD8 + T cells (Fig. 8) . This analysis was performed in order to determine if resolution of bivalency was likely to have occurred prior to performing epigenetic analysis. In this case, there was no significant decrease in the level of T-bet protein in activated CD4 + and CD8 + T cells following IAV infection of Luc shRNA and Kdm6b shRNA mice (Fig. 8a) , despite an overall lower, albeit modest, level of Kdm6b RNA (Fig. 8b) . Hence, perhaps unsurprisingly, there was little difference in the expression of transcription factor genes with bivalent loci in activated, polyclonal CD4 + or CD8 + T cells from either mouse strain (Fig. 8c) . (Fig. 9a) .
Importantly, this same trend was not observed at the Tbx21 loci in activated GFP med-hi CD4 + T cells, nor at the loci of other transcription factors analysed in both CD8 + and CD4 + T cells (Fig. 9a) .
Interestingly, in activated GFP med-hi CD8 + T cells there was an increase in the active modification H3K4me3 at Ifr4 and Irf8 loci, and suggesting a possible mechanism for the similar transcription levels between cells with the Luciferase and Kdm6b hairpin, despite the lack of difference in deposition of the repressive H3K27me3 (Fig. 7a, b) . However, this trend was not consistent for the T-box transcription factors Tbx21 and Eomes (Fig. 7b) . Therefore, it remains unclear why the CD8 + T cells from mice harbouring the Kdm6b hairpin are able to express the T-bet protein and RNA despite the locus remaining unresolved in its chromatin state. It is possible that perhaps given that ChIP is a bulk assay, we are unable to discriminate those cells expressing T-BET that have lost H3K27me3. Further, it is important to note that the unresolved Tbx21 loci in the presence of the Kdm6b hairpin does not appear to be a general mechanism as it is not seen in CD4 + T cells. Finally, the actin loci is used as a control and is expected to have constitutive deposition of H3K4me3 and lack H3K27me3. In the presence of the Kdm6b hairpin we see a decrease in the deposition of H3K4me3 at this locus possibly suggesting a general decrease in accessibility of chromatin in cells harbouring the Kdm6b hairpin. 
Discussion
The use of RNAi mediated gene silencing induced by shRNA expression within a microRNA backbone is a potent way to decrease target gene expression (20) . The utility of this system was demonstrated in an early study by Dickins et al. demonstrating that induction of shRNA knockdown targeting the tumour suppressor, p53, resulted in the development of tumours, with restoration of p53 expression resulting in decreased tumour burden (21) . This use of tetracycline responsive regulatory element provides a powerful tool to be able to either turn on or turn off constitutive shRNA transcription. This study describes the development of two mouse lines designed to enable inducible and reversible hairpin mediated knockdown of the epigenetic modifier KDM6b.
We first generated mice where Kdm6b knockdown was induced upon addition of doxycycline to drinking water or food. By crossing Kdm6b shRNA or Luc shRNA transgenic mice with CAG-rtTA3 (Tet-ON) mice, robust shRNA expression upon doxycycline induction was evident in adaptive immune cell subsets (25) . Using this system would enable shRNA expression to be induced at any stage during an immune response in vivo. Interestingly, this system appears to function well in developing thymocytes, yet some mature T cell subsets have been reported to be refractory to to shRNA transcription. Nevertheless, this system provides increased flexibility and precision in understanding when this epigenetic modifier plays a role in the programming of multiple immune cell types.
An advantage of the shRNA mediated knockdown system, compared to permanent gene mutation or removal is that the target gene is depleted instead of being completely deleted (22) . In some cases this more accurately reflects human disease (24, 32) . For example, it has been demonstrated that Kdm6b deletion can lead to embryonic lethality (33) or deformity (34, 35) . Hence, the ability to control KDM6b knockdown via shRNA induction enables this issue to be overcome.
To that end, we established a line of mice using the "Tet-OFF" system whereby there is constitutive Kdm6b shRNA dependent knockdown that can be reversed by addition of doxycycline (Kdm6b shRNA .VavtTA mice). We were able to demonstrate Kdm6b knockdown in a variety of immune cell types including immature thymocytes and mature T cells. Our preliminary analysis of thymocyte development indicated that KDM6b may play a role in T cell development in the thymus, specifically during transition from the DN1-DN2 stage. Recently, Manna and colleagues have shown that both KDM6b and the related enzyme UTX are essential for terminal thymocyte differentiation, specifically due to their ability to remove the repressive H3K27me3 mark from genes associated with egress such as S1pr1 (36) . Dynamic changes in H3K27me3 deposition is a characteristic of thymocyte differentiation (37) . This system therefore may be useful to further delineate the precise role of KDM6b in this process.
We observed, even with a relatively modest knockdown of Kdm6b, fewer mature CD4 + T cells in the periphery, both in the naïve state and following IAV infection. While the defect in the DN2 transition maybe an explanation, there was no impact on either DP or SP populations, and no impact on the mature CD8+ T cell numbers in the periphery making this unlikely. It was interesting to note that mature, naive H3K27me3 is a major consequence of virus-specific CD8 + T cell activation (15) (16) (17) . Importantly, we identified a subset of gene promoters that exhibited bivalency for both H3K4me3 and H3K27me3. These loci marked transcription factors, such as Tbx21, known to play important roles in optimal virus-specific CD8+ T cell differentiation (43) (44) (45) . Given these results, we speculated that KDM6b induction is a key step for optimal virus-specific CD8+ T cell differentiation. To that end, we observed that the bivalent Tbx21 locus failed to resolve to a transcriptionally permissive state (H3K4me3+) in Kdm6b shRNA activated CD8+
T cells. Interestingly, we saw little difference in the expression T-BET, and other key lineage specific transcription factors within IAV-specific T cells. Moreover, other bivalent loci such as Irf4, Irf8, and Eomes were able to be resolved to a permissive state. Furthermore, the Tbx21 promoter was resolved in activated CD4 + T cells, indicating that KDM6b mediated resolution of bivalency at the Tbx21 promoter was a CD8 + T cell specific mechanism. So while there is some hint that H3K27me3 removal from the Tbx21 promoter is KDM6b dependent, and this correlates with a reduced virus-specific CD8+ T cell response, it remains to be determined whether this is a direct or indirect effect. Analysis of genome wide patterns of H3K27me3 deposition within both Kdm6b shRNA and Luc shRNA virus-specific T cells may provide more mechanistic information.
Another possibility for the subtle observations made is that there is a KDM6b homologue, KDM6a
(UTX), that is also a H3K27 demethylase. Interestingly, it has been shown to be essential for embryonic development via a mechanism that is independent of its H3K27 demethylase activity (33) . This demethylase independent function appears to be due to its the ability of UTX to bind the genome and recruit signalling factors (46, 47) . Hence, the subtle differences observed may be due to overlapping or secondary roles of UTX in regulating T cell specific gene transcription.
An interesting note is that studies by Weinmann and colleagues have shown that KDM6b and UTX can interact with T-bet directly enabling TF regulation of TFs that is independent of H3K27 demethylase activity (48) . It was demonstrated that physical interactions can occur between T-bet, Set7/9 H3K4 methyltransferases, and also the chromatin remodelling Brg1-containing SWI/SNF complex (13, 48, 49) were dependent on KDM6b, UTX, but did not require H3K27 demethylase activity. This provides a basis of how KDM6b can be recruited and co-locate to H3K4me3-marked loci and contribute to gene transcription and also how KDM6b is able to be recruited to target genes (50) . Given the important role of T-bet in ensuring optimal virus-specific T cell responses, perhaps KDM6b knockdown is limiting the ability of T-bet to bind to target loci due to diminished KDM6b interactions. This would provide an explanation of why we see no significant difference in T-bet expression levels, yet observed diminished IAV-specific CD8+ T cell responses. In line with this possibility, we also observed decreased IFN-g production, a known T-BET target gene, within IAV-specific CD8+ T cells. Analysis of T-bet binding to target gene loci within the Kdm6b shRNA T cells via chromatin immunoprecipitation assays will provide further information about this potential mechanism.
